Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Business_Executive
|
| gptkbp:birth_place |
gptkb:Denmark
|
| gptkbp:birth_year |
gptkb:1965
|
| gptkbp:debut_year |
gptkb:2017
|
| gptkbp:education |
gptkb:Copenhagen_Business_School
|
| gptkbp:has_influence_on |
gptkb:pharmaceuticals
|
| gptkbp:has_role |
gptkb:CEO
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kåre Schultz
|
| gptkbp:industry |
gptkb:pharmaceuticals
|
| gptkbp:known_for |
turnaround strategies
CEO of Teva Pharmaceutical Industries |
| gptkbp:nationality |
gptkb:Danish
|
| gptkbp:position |
gptkb:CEO
CEO of H. Lundbeck A/ S |
| gptkbp:predecessor |
gptkb:Erez_Vigodman
|
| gptkbp:production_company |
gptkb:pharmaceuticals
|
| gptkbp:role |
business leader
|
| gptkbp:successor |
gptkb:N/_A
|
| gptkbp:website |
www.tevapharm.com
|
| gptkbp:works_at |
gptkb:pharmaceuticals
|
| gptkbp:years_active |
1990-present
|
| gptkbp:bfsParent |
gptkb:Teva
gptkb:pharmaceuticals |
| gptkbp:bfsLayer |
4
|